David Vidal

Critic
DISC Type : C

Chief Technology Officer at PharmEnable Therapeutics

Greater Barcelona Metropolitan Area, Spain

Overview

David Vidal is the Chief Technology Officer at PharmEnable Therapeutics, bringing over 20 years of experience as a computational scientist and chemist to the field of drug discovery. He leads the companys computational R&D and CADD team, leveraging his expertise in machine learning and cheminformatics. He earned his PhD at the Universitat de Barcelona.

David is passionate about applying computation to solve meaningful problems in drug discovery. He has shown concern for broader societal issues, such as humanitarian aid for flooding victims in Spain, and stays informed on scientific advancements beyond his immediate field, including breakthroughs in cancer research.

He is a self-described "vocational drug hunter, " reflecting his deep-seated passion for the scientific pursuit of new medicines.

Personality Overview

ROI Driven

Information Seeker

Precise

They prefer to do logical analysis and value evidence over emotions.  They don’t appreciate bells and whistles unless backed by data. They enjoy working alone and do not rely on others very often.

Topics They Care About

Computational Drug Discovery
With over 20 years of experience, he leads computational R&D at PharmEnable, specializing in CADD, cheminformatics, and molecular modeling to find new drugs.
AI in Drug Discovery
He has a certification in Deep Learning and focuses on implementing innovative AI-based modeling techniques as part of PharmEnable's discovery platform.
Thoughtful Team Leadership
Described as a thoughtful team leader focused on strategy and collaboration, he aims to build environments where scientists and engineers can do their best work.

Media Appearances

David has no verified media appearances

Work History

8-2024
Chief Technology Officer at PharmEnable Therapeutics
10-2019 - 7-2024
Director Technology at PharmEnable Therapeutics
4-2019 - 4-2021
Cheminformatics Expert at Tata Consultancy Services
7-2017 - 12-2018
Director R&D at Mind the Byte
11-2016 - 6-2017
Head In Silico Pharmacology at Mind the Byte

Education

2002 - 2006
PhD from Universitat de Barcelona
1994 - 1999
ScB from Universitat Jaume I

More Information

Social Presence :

Prographics :

Exp : 18 Location : Greater Barcelona Metropolitan Area, Spain Job Level : Leadership Designation : Chief Technology Officer at PharmEnable Therapeutics
URL has been copied!

Insights For Selling To David

During A Call Or A Meeting

DO's

  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Tell them what ROI they can expect
  • Leverage facts and figures wherever possible; use percentages, numbers etc.

DONT's

  • Don't give superficial answers, they are easily rattled by them
  • Don’t rush them till they have clearly gotten all the necessary information
  • Make extra effort to not seem pushy or confrontational

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with David is

  • Strong evidence of ROI, effective pricing, and proven data points matter the most to them.
  • Will you ever get a clear answer from David

  • It is not very hard for them to say no if they are not convinced about the decision.

Insights For Deal Planning

    How fast (or slow) will David move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can David take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And David

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.